HighCom (HCL) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
23 Nov, 2025Executive summary
Achieved a significant turnaround in FY25, returning to positive EBITDA of $0.2 million after a large loss in FY24, driven by cost reductions, inventory optimization, and recommissioning of the XTclave production line.
Revenue grew 6% year-over-year to $48.1 million, with the U.S. business up 10% and technology division flat due to contract timing.
Major investment in XTclave and a full business review have positioned the company for growth and margin improvement in FY26.
Cost controls, inventory reduction, and a new executive team contributed to operational stabilization.
Net loss narrowed to $1.2 million from $12.0 million in FY24.
Financial highlights
EBITDA increased by $9.8 million to $0.2 million, marking a return to profitability.
Revenue rose to $48.1 million, up 6% year-over-year; gross profit was $11.0 million, down $2.4 million from FY24.
Cash balance at year-end was $5.8 million, with no debt and $3.8 million in available debt facilities.
Gross margin declined to 23% from 30% due to discounted sales and clearing impaired inventory.
Employee costs reduced by $1.7 million and operating expenses by $2.7 million.
Outlook and guidance
Anticipates increased gross margins in FY26 as new XTclave products launch and impaired inventory is cleared.
Expects revenue and EBITDA growth in FY26 without materially increasing operating costs.
Defense sector outlook remains strong due to global geopolitical instability and rising defense spending.
Short-term challenges in Q1 FY26 due to US government funding delays.
Latest events from HighCom
- Revenue fell 49% to $45.3m with a $12m net loss, but H2 EBITDA turned positive.HCL
H2 202426 Mar 2026 - Revenue fell 59% to $10.9m and EBITDA turned negative, but strong H2 recovery is expected.HCL
H1 20262 Mar 2026 - Capital raise supports growth, XTclave® upgrades, and a return to profitability in H2 FY26.HCL
Investor presentation11 Feb 2026